selected publications
-
academic article
- The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.. BMC cancer. 21:-. 2021
- Activation of Rho Family GTPases by Small Molecules.. ACS chemical biology. 13:1514-1524. 2018
- R-ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.. Molecular cancer therapeutics. :-. 2015
- A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. :-. 2015
- A Pan-GTPase Inhibitor as a Molecular Probe. 2015
- Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. 2015